Abstract: The disclosure provides for a lab-on-a-chip (LOC) deviceand a method of fabrication thereof. Additionally, a system and a methodfor pointof care testing of multiple biomarkers such as glucose, cholesterol, creatinine, uric acid, and bilirubinis provided.The microfluidic assembly consists of three layers in which the top and the middlelayers are made up of polydimethylsiloxane (PDMS) andthe bottom layer with polyethylene terephthalate (PET). The device integrates screen printed non-enzymatic electrochemical sensors in the bottom layer for simultaneous detection of glucose, cholesterol, creatinine, uric acid, and bilirubin. A hand held potentiostat with readout enables readoutfor the point of care application of integrated sensing device.The device developed has potential to revamp healthcare by providing access to affordable technology for better management of diabetes and related complications at every door step.
DESC:See attachment ,CLAIMS:See attachment
| # | Name | Date |
|---|---|---|
| 1 | 201841004049-STATEMENT OF UNDERTAKING (FORM 3) [02-02-2018(online)].pdf | 2018-02-02 |
| 2 | 201841004049-PROVISIONAL SPECIFICATION [02-02-2018(online)].pdf | 2018-02-02 |
| 3 | 201841004049-POWER OF AUTHORITY [02-02-2018(online)].pdf | 2018-02-02 |
| 4 | 201841004049-FORM 1 [02-02-2018(online)].pdf | 2018-02-02 |
| 5 | 201841004049-DRAWING [03-09-2018(online)].pdf | 2018-09-03 |
| 6 | 201841004049-COMPLETE SPECIFICATION [03-09-2018(online)].pdf | 2018-09-03 |
| 7 | 201841004049-FORM 3 [16-09-2019(online)].pdf | 2019-09-16 |
| 8 | 201841004049-FORM 3 [02-11-2021(online)].pdf | 2021-11-02 |
| 9 | 201841004049-FORM 18A [02-02-2022(online)].pdf | 2022-02-02 |
| 10 | 201841004049-EVIDENCE OF ELIGIBILTY RULE 24C1h [02-02-2022(online)].pdf | 2022-02-02 |
| 11 | 201841004049-EVIDENCE FOR REGISTRATION UNDER SSI [02-02-2022(online)].pdf | 2022-02-02 |
| 12 | 201841004049-EDUCATIONAL INSTITUTION(S) [02-02-2022(online)].pdf | 2022-02-02 |
| 13 | 201841004049-FER.pdf | 2022-02-04 |
| 14 | 201841004049-RELEVANT DOCUMENTS [03-08-2022(online)].pdf | 2022-08-03 |
| 15 | 201841004049-POA [03-08-2022(online)].pdf | 2022-08-03 |
| 16 | 201841004049-FORM 13 [03-08-2022(online)].pdf | 2022-08-03 |
| 17 | 201841004049-FORM 13 [03-08-2022(online)]-1.pdf | 2022-08-03 |
| 18 | 201841004049-FER_SER_REPLY [03-08-2022(online)].pdf | 2022-08-03 |
| 19 | 201841004049-DRAWING [03-08-2022(online)].pdf | 2022-08-03 |
| 20 | 201841004049-COMPLETE SPECIFICATION [03-08-2022(online)].pdf | 2022-08-03 |
| 21 | 201841004049-CLAIMS [03-08-2022(online)].pdf | 2022-08-03 |
| 22 | 201841004049-AMMENDED DOCUMENTS [03-08-2022(online)].pdf | 2022-08-03 |
| 23 | 201841004049-Proof of Right [04-08-2022(online)].pdf | 2022-08-04 |
| 24 | 201841004049-PETITION UNDER RULE 137 [04-08-2022(online)].pdf | 2022-08-04 |
| 25 | 201841004049-US(14)-HearingNotice-(HearingDate-10-10-2022).pdf | 2022-09-19 |
| 26 | 201841004049-Correspondence to notify the Controller [08-10-2022(online)].pdf | 2022-10-08 |
| 27 | 201841004049-Written submissions and relevant documents [21-10-2022(online)].pdf | 2022-10-21 |
| 28 | 201841004049-Annexure [21-10-2022(online)].pdf | 2022-10-21 |
| 1 | 4feb201841004049_searchE_04-02-2022.pdf |